Approval · Notice of Compliance 2575 · 2001
SEPTRA: Notice of Compliance 2575
Issued August 15, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2575
- Date
- August 15, 2001
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in manufacturer name
- Therapeutic class
- Antibacterial agent
Products in this notice
Medicinal ingredients
- SULFAMETHOXAZOLE 80 MG per ML
- TRIMETHOPRIM 16 MG per ML
- SULFAMETHOXAZOLE 40 MG per ML
- TRIMETHOPRIM 8 MG per ML
- SULFAMETHOXAZOLE 400 MG per TAB
- TRIMETHOPRIM 80 MG per TAB
- SULFAMETHOXAZOLE 800 MG per TAB
- TRIMETHOPRIM 160 MG per TAB